Biocon Biologics (BBL) has a debt of $1.2 billion to fund the acquisition of Viatris' biosimilars business.
Speaking to Business Standard, Kedar Upadhye, CFO of Biocon Biologics said the company now has access to the international capital market and this provides them with a lot of financial flexibility. "It improves our liquidity, profile, and obviously a little bit of a savings in the interest rate as well," he said.
Denne historien er fra October 04, 2024-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra October 04, 2024-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
MODEL CODE OF CONSTRUCT
Apple is replicating its China model of manufacturing in India, with tweaks. How is it working out?
Money in the bank
The cash reserve ratio's use to ensure monetary stability is being debated as lenders' deposit growth slows down, reports RAGHU MOHAN
How India made M&A easier for companies
The aspirations of a young India and increased income levels have encouraged companies to consider mergers and acquisitions (M&A) to keep up with demand.
Rising home prices: Consider outskirts, in-progress projects
But be mindful of the potential drawbacks of these options and make balanced choices
Retail investors vs algos: Like lambs to slaughter
TRUTH BE TOLD
FROTH RISING? MIDCAP AND SMALLCAP VALUATIONS ON BRINK OF OVERFLOW
A BUBBLE WAITING TO BURST?
Mutual funds hoist sails, catch the wind of growth
CHARTING COURSE TO CALM: With record equity inflows of ₹2.8 trillion in FY25, they provide the ballast that steadies the ship amid choppy FPI exits
Largecap lineup may get a new cast: 9 entrants, 9 exit stage
NEW SCRIPT, NEW BENCHMARK: Curtain to rise on new act as largecap eligibility cut-off nears ₹1 trn ahead of Jan review
Melania Trump whitewashes a presidency
BOOK REVIEW
Jhunjhunwala inspires new investors
India's equity markets, wealth management, and asset management industries are in a golden age, highlights HIREN VED, director and chief investment officer at Alchemy Capital Management, in conversation with Puneet Wadhwa. Excerpts:
